|
Volumn 14, Issue 5, 2012, Pages 551-554
|
Anti-tuberculosis prophylaxis following renal transplantation: Acceptable variations?
|
Author keywords
Prophylaxis; Renal transplant; Tuberculosis
|
Indexed keywords
ISONIAZID;
PYRIDOXINE;
TUBERCULOSTATIC AGENT;
ARTICLE;
CHEMOPROPHYLAXIS;
CLINICAL PRACTICE;
ENDEMIC DISEASE;
HEALTH CARE POLICY;
HIGH RISK PATIENT;
HUMAN;
INFECTION RISK;
KIDNEY TRANSPLANTATION;
ORGAN TRANSPLANTATION;
PATIENT SELECTION;
PHARMACIST;
PHYSICIAN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK REDUCTION;
TREATMENT DURATION;
TREATMENT INDICATION;
TREATMENT RESPONSE;
TUBERCULOSIS;
TUBERCULOSIS CONTROL;
UNITED KINGDOM;
ANTIBIOTIC PROPHYLAXIS;
ANTITUBERCULAR AGENTS;
FEMALE;
GREAT BRITAIN;
HEALTH POLICY;
HUMANS;
INCIDENCE;
ISONIAZID;
KIDNEY TRANSPLANTATION;
MALE;
TUBERCULOSIS;
|
EID: 84867645551
PISSN: 13982273
EISSN: 13993062
Source Type: Journal
DOI: 10.1111/j.1399-3062.2012.00717.x Document Type: Article |
Times cited : (6)
|
References (9)
|